ArticleFrontiers in pharmacology2025
HPV vaccine-related thyroid adverse events: temporal patterns and reporting trends.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human papillomavirus (HPV) vaccination is essential for cervical cancer prevention, but concerns about thyroid-related adverse events (AEs) have emerged. Methods: This pharmacovigilance study aimed to assess potential associations between HPV vaccination and thyroid disorders using spontaneous report data. Reports from the U.S. Vaccine Adverse Event Reporting System through 31 December 2024, were analyzed. Disproportionality analyses (PRR, ROR, BCPNN, MGPS) were performed, with subgroup analyses by gender, age, and vaccine type. A Weibull shape parameter model assessed the temporal risk pattern. Results: Among 60,840 HPV vaccine-related reports, 13 thyroid-associated AEs showed positive signals. Hypothyroidism (ROR = 11.65) and autoimmune thyroiditis (ROR = 4.26) were the strongest signals. Most cases occurred in females under 65 years. HPV-4 was linked to 72.8% of thyroid AEs. The cumulative reporting rate reached 69.1% within 180 days. Conclusion: Our findings suggest a potential association between HPV vaccination and thyroid disorders, notably hypothyroidism and autoimmune thyroiditis. Continued pharmacovigilance and further mechanistic investigations are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.